Literature DB >> 15325956

Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes.

T Palomo1, R J Beninger, R M Kostrzewa, T Archer.   

Abstract

A multitude of factors, that either singly, interactively, or sequentially influence the gene-environment interplay in affective and dementia states, include several phases of neurodevelopmental liability in both humans and laboratory animals. Genetic vulnerability for both affective disorders and dementia describes a scenario distinguished by progressive need for concern, particularly in view of the interplay between these areas of ill-health. The contribution of emotional and cognitive expression to personal outcomes, e.g., as a function of affective personality type, a state-dependent analysis of personality characteristics, appears to pervade both the individual's experience of social and physical environments and the performance of cognitive tasks. The role of the endocannabinoids in mental health may offer insights for the psychopharmacology of both cognition and affect. Maladaptive emotional reactions and a defective cognitive ability will contribution to unsatisfactory/maladaptive coping strategies, in turn, leading to further complications of an affective and dysfunctional nature, eventually with a clinical psychopathological outcome. These considerations impinge upon critical issues concerning predisposition and vulnerability. Classical eye-blink conditioning provides a highly established procedure for assessment of defective physiology in models of Alzheimer's dementia. In order to develop a consideration of the array of situations presenting the variation of outcome due to type of affective personality, the role of fear and anxiety and stress in affective states influencing cognition are examined and the critical role of brain circuits mediating emotions influencing cognitive outcomes is discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15325956     DOI: 10.1007/bf03033219

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  154 in total

Review 1.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

2.  The amygdala modulates memory consolidation of fear-motivated inhibitory avoidance learning but not classical fear conditioning.

Authors:  A E Wilensky; G E Schafe; J E LeDoux
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Subcortical and cortical brain activity during the feeling of self-generated emotions.

Authors:  A R Damasio; T J Grabowski; A Bechara; H Damasio; L L Ponto; J Parvizi; R D Hichwa
Journal:  Nat Neurosci       Date:  2000-10       Impact factor: 24.884

4.  Emotion processing in Alzheimer's disease.

Authors:  R S Bucks; S A Radford
Journal:  Aging Ment Health       Date:  2004-05       Impact factor: 3.658

5.  Rapid and transient learning-associated increase in NMDA NR1 subunit in the rat hippocampus.

Authors:  M Cammarota; M L de Stein; G Paratcha; L R Bevilaqua; I Izquierdo; J H Medina
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

6.  Neurons in medial prefrontal cortex signal memory for fear extinction.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Nature       Date:  2002-11-07       Impact factor: 49.962

7.  Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

Authors:  M Navarro; E Hernández; R M Muñoz; I del Arco; M A Villanúa; M R Carrera; F Rodríguez de Fonseca
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

8.  Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop.

Authors:  G Bush; J A Frazier; S L Rauch; L J Seidman; P J Whalen; M A Jenike; B R Rosen; J Biederman
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

9.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

10.  Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants.

Authors:  Cyril Rocher; Michael Spedding; Carmen Munoz; Thérèse M Jay
Journal:  Cereb Cortex       Date:  2004-02       Impact factor: 5.357

View more
  9 in total

Review 1.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: executive functions and locus of control.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

3.  Affective personality as cognitive-emotional presymptom profiles regulatory for self-reported health predispositions.

Authors:  T Archer; B Adolfsson; E Karlsson
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

Review 4.  Movement disorders: neurodevelopment and neurobehavioural expression.

Authors:  T Archer; R J Beninger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

Review 5.  Transcription factor AP-2 and monoaminergic functions in the central nervous system.

Authors:  M Damberg
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

6.  Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

7.  Focusing on symptoms rather than diagnoses in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

Review 8.  Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

Review 9.  Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.